High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV‐infected patients treated in a real‐life setting
Massimiliano Fabbiani(University of Siena), Andrea Lombardi(University of Milan), Alessandro Soria(University of Milano-Bicocca), Chiara Baiguera(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Ana Lleò(Humanitas University), Roberta D’Ambrosio(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Francesco Castelli(University of Brescia), Alessio Aghemo, L. Pasulo(Ospedale Papa Giovanni XXIII), Alessia Giorgini(Università Cattolica del Sacro Cuore), Clara Dibenedetto, Raffaele Bruno(University of Pavia), Marta Colaneri(University of Milan), Ombretta Spinelli(Azienda Socio Sanitaria Territoriale Lariana), Paolo Perini(Ospedale San Pietro Fatebenefratelli), Elisabetta Degasperi(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), S. Fagiuoli(Ospedale Papa Giovanni XXIII), Monica Schiavini(ASST Fatebenefratelli Sacco), Maria Grazia Rumi(University of Milan), Pietro Lampertico(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), P. Del Poggio, Paola Brambilla(University of Milan), Tiziana Re
Cited by 12
Related Papers
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|The Lancet. Gastroenterology & hepatology|2022|664
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
|Journal of Clinical Investigation|1996|661
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539